Примери за използване на Evidence of teratogenicity на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Animal data revealed no evidence of teratogenicity.
There was no evidence of teratogenicity in rats or rabbits treated with the losartan/ hydrochlorothiazide combination.
There was no effect on foetal development and no evidence of teratogenicity.
There was no evidence of teratogenicity in rats or rabbits.
Studies in laboratory animals have not produced any evidence of teratogenicity.
Vemurafenib revealed no evidence of teratogenicity in rat or rabbit embryo/foetuses(see section 5.3).
Higher doses resulted in maternal and foetal toxicity without evidence of teratogenicity.
Studies in animals have shown no evidence of teratogenicity or abnormal parturition.
Reproductive studies performed in rats andrabbits indicated that placental transfer of zanamivir occurs and there was no evidence of teratogenicity.
There was no evidence of teratogenicity with the combination of cilazapril and hydrochlorothiazide in rats and mice.
Studies in animals with bictegravir have shown no evidence of teratogenicity or an effect on reproductive function.
There was no evidence of teratogenicity(rat and rabbit), or abnormal pre- or post-natal physical or behavioural development(rat).
Reproduction toxicity studies in animals showed no evidence of teratogenicity or adverse effects on male fertility.
There was no evidence of teratogenicity following administration of retigabine to pregnant animals during the period of organogenesis.
Animal studies with racemic citalopram have revealed evidence of teratogenicity at doses greater than human therapeutic doses.
There was no evidence of teratogenicity, embryotoxicity or foetotoxicity in rats or mice that received up to 1000 mg/kg/day tadalafil.
Studies in animals have shown developmental toxicity, but no evidence of teratogenicity, at doses that are maternally toxic(see section 5.3).
In pregnant rats, no evidence of teratogenicity, embryotoxicity, or fetotoxicity was observed at doses up to 300 mg/kg/day(approximately 15 times the MRHD on a mg/m basis in a 60 kg subject).
Studies in animalsperformed with vildagliptin and metformin have not shown evidence of teratogenicity, but foetotoxic effects at maternotoxic doses(see section 5.3).
Reproductive toxicology studies demonstrated no adverse effects on male and female fertility orpostnatal development of offspring in rats and there was no evidence of teratogenicity in rats.
Reproductive studies in animals have not shown evidence of teratogenicity, and showed no effect on male or female fertility.
Developmental Toxicity Developmental toxicity studies were performed in rats, rabbits and dogs(at doses which produced systemic exposures comparable to or slightly greater than human exposure)and revealed no evidence of teratogenicity.
Animal studies have shown no evidence of teratogenicity but embryolethality was seen in both rat and rabbit studies(see section 5.3).
Reproductive toxicology studies demonstrated no adverse effects on male and female fertility orpostnatal development of offspring in rats and there was no evidence of teratogenicity in rats(1,000 mg/kg/day) or rabbits(300 mg/kg/day).
Pegaptanib produced no maternal toxicity and no evidence of teratogenicity or foetal mortality in mice at intravenous doses of 1 to 40 mg/kg/day.
When doses of imipenem-cilastatin sodium(approximately 100/100 mg/kg/day or approximately 3 times the usual recommended daily human intravenous dose) were administered to pregnant cynomolgus monkeys at an intravenous infusion rate which mimics human clinical use, there was minimal maternal intolerance(occasional emesis),no maternal deaths, no evidence of teratogenicity, but an increase in embryonic loss relative to control groups(see section 4.6).
Reproductive studies in animals have not shown evidence of teratogenicity and showed no effect on male or female fertility.
And monkeys(p.o.) did not show evidence of teratogenicity or impairment of fertility following administration of moxifloxacin.
Evidence of the teratogenicity of 6-mercaptopurine in humans is equivocal.
Animal studies have not shown any evidence of foetotoxicity or teratogenicity(see section 5.3).